These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23566533)

  • 21. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
    Wada T; Yamakawa K; Kabata D; Abe T; Ogura H; Shiraishi A; Saitoh D; Kushimoto S; Fujishima S; Mayumi T; Hifumi T; Shiino Y; Nakada TA; Tarui T; Otomo Y; Okamoto K; Umemura Y; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S; Gando S
    Sci Rep; 2022 Jun; 12(1):9304. PubMed ID: 35660774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery.
    Hashimoto D; Okawa T; Maruyama R; Matsumura F; Shibata Y; Kohrogi H
    Anticancer Res; 2019 Jan; 39(1):25-31. PubMed ID: 30591437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
    Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial.
    Aikawa N; Shimazaki S; Yamamoto Y; Saito H; Maruyama I; Ohno R; Hirayama A; Aoki Y; Aoki N
    Shock; 2011 Apr; 35(4):349-54. PubMed ID: 21068698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation abnormalities in sepsis.
    Tsao CM; Ho ST; Wu CC
    Acta Anaesthesiol Taiwan; 2015 Mar; 53(1):16-22. PubMed ID: 25544351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.
    Hook KM; Abrams CS
    Clin Transl Sci; 2012 Feb; 5(1):85-92. PubMed ID: 22376264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T; Saitoh D; Wada H; Asakura H
    Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
    Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.